Vimarsana
Biggest News Aggregation in the World

Page 39 - Kodiak Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kodiak Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kodiak Sciences Today - Breaking & Trending Today

Kodiak Sciences Completes Enrollment in GLEAM and GLIMMER Phase 3 Clinical Trials of KSI-301 in Patients with Diabetic Macular Edema - Vimarsana News

Kodiak Sciences Completes Enrollment in GLEAM and GLIMMER Phase 3 Clinical Trials of KSI-301 in Patients with Diabetic Macular Edema

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...

Kodiak Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference - Vimarsana News

Kodiak Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...

Kodiak Sciences Completes Enrollment in BEACON Phase 3 Clinical Trial of KSI-301 in Patients with Retinal Vein Occlusion - Vimarsana News

Kodiak Sciences Completes Enrollment in BEACON Phase 3 Clinical Trial of KSI-301 in Patients with Retinal Vein Occlusion

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...

BioSpace Mover & Shakers, Oct. 22 - Vimarsana News

BioSpace Mover & Shakers, Oct. 22

BioSpace Mover & Shakers, Oct. 22 - read this article along with other careers information, tips and advice on BioSpace

Chutes & Ladders—Athira CEO resigns after investigation confirms she altered research - Vimarsana News

Chutes & Ladders—Athira CEO resigns after investigation confirms she altered research

Athira Pharma's CEO resigns after investigation confirms she altered research during graduate school. vTv Therapeutics named healthcare investor Deepa Prasad its new CEO and president. Opus Genetics snagged a new chief scientific officer and chief operating officer.